Skip to content

APOTHEEK BOSPOORT

Active
Private limited companyfounded 1984active for 41 yearsBospoort 12, 3680 Maaseik, BelgiumKBO/BCE: BE 0426.680.036
Summary

APOTHEEK BOSPOORT has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €908,418 and a net result of €66,552. Equity is growing by about 6.1% per year across the filed financial years. Its solvency ranks better than 91% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK BOSPOORTActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
6th oldest company in Maaseik, Wholesale and retail trade sector1 site
Size
≈ €1.4mturnover 2025, estimated
Staff
3.3 FTE
Equity
€908,418
Profit
€66,552
Turnover estimated from the gross margin
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
SODIAP · 100%
  • ALEXOChair · permanent representative Olivier Delaere
  • BV KST PharmaDirector · permanent representative Koen Straetmans
2025 accounts 80 days early2 of 9 deeds summarised
Why 94raises riskSector: Retail trade (NACE 47)lowers riskFounded in 1984Equity €908,418 (82.6% of total assets)Size: 3.3 FTE, total assets €1.1mShow the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 65% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100=
equity 82.6% of total assets
Liquidity 46=
short-term debt 17.4% · cash 0.6%
Profitability 76+1
return on assets 6.0%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,259 companies, NACE 47, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.3%▲ +0.1 percentage points vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025highest value 07-2025: 0.2%▼ -0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.1%▼ -0.1 percentage points vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026lowest value 10-2026: 0.1%● unchanged vs 09-2026lowest value
Credit of up to €85,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.52, compared with 2.14 in 2024, above the usual 1.5; short-term debt: 17.4% and cash: 0.6% of total assets), and 17.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 92% on solvency, 45% on liquidity, 64% on profitability and 57% on growth.

The bankruptcy probability was computed on 28-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Founded in 1984
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Equity €908,418 (82.6% of total assets)
NBB · annual accounts
lowers risk · Size: 3.3 FTE, total assets €1.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-05-2026, 80 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
80 days early
2024
45 days early
2023
49 days early
2022
52 days early
2021
54 days early
2020
47 days early
2019
17 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 49 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
29-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: BV ALEXO (director)Permanent representatives: Olivier Delaere, Koen…
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Annual accounts filedfinancial year 2024 · abbreviated…

Key points

  • Positive: Among the best 10% on solvencysector median 36.6% · 12,713 companies 82.6% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €66,552 8 years View
  • Controlled by SODIAPultimately: PHARMACIE BIA 100% View
  • New directorlatest change 19-05-2026 · 2 in office 1 joined View

By topic

Financials

Financial year
2025
Total assets
€1.1m
Profit
€66,552
Solvency
82.6%
Total assets▲ 8.3%
Net result
20182025
Go to Financials

Timeline

Events
44
Since
1986
Next accounts
by 31-07-2027
  1. 12-06-2024Annual accounts filed
  2. 31-12-2023Weakest financial year
  3. 09-06-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
13-12-1984
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about APOTHEEK BOSPOORT

What is the company number of APOTHEEK BOSPOORT?
0426.680.036. In Belgium the VAT number is the company number with BE in front: BE 0426.680.036.
Where is APOTHEEK BOSPOORT based?
The registered office is at Bospoort 12, 3680 Maaseik.Company details
What does APOTHEEK BOSPOORT do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK BOSPOORT?
Private limited company (BV).
When was APOTHEEK BOSPOORT founded?
On 13-12-1984.
Is APOTHEEK BOSPOORT still active?
Yes, APOTHEEK BOSPOORT is an active enterprise in the KBO register.
How many employees does APOTHEEK BOSPOORT have?
On average 3.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK BOSPOORT?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK BOSPOORT profitable?
In financial year 2025, APOTHEEK BOSPOORT made a profit of €66,552.
Where can I find the annual accounts of APOTHEEK BOSPOORT?
APOTHEEK BOSPOORT filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK BOSPOORT due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK BOSPOORT

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check Which other companies belong to the same group?PHARMACIE BIA · 40 companies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure